XML 89 R34.htm IDEA: XBRL DOCUMENT
v2.4.0.8

Acquisitions (Tables) | 12 Months Ended
--- | ---
Jun. 30, 2014
Reconciliation of Consideration Transferred to Total Cash Paid to Acquire Business | The following table reconciles consideration transferred to the total cash paid to acquire Crescendo:
(In thousands) |  |  |
Total consideration transferred |  | $ | 258,950 |
Share-based compensation to Crescendo employees |  |  | 6,929 |
Change of control payments to Crescendo employees |  |  | 5,695 |
Offset: Non-cash fair value purchase option |  |  | (8,000 | )
Total cash paid |  | $ | 263,574 |
Allocation of Consideration Transferred for Crescendo | The Company’s allocation of consideration transferred for Crescendo is as follows (in thousands):
(In thousands) |  | Estimated Fair Value |
Other assets acquired |  | $ | 15,826 |
Intangible assets |  |  | 196,600 |
Goodwill |  |  | 112,331 |
Total assets acquired |  |  | 324,757 |
Deferred tax liability |  |  | 44,213 |
Other liabilities assumed |  |  | 21,594 |
Total net assets acquired |  | $ | 258,950 |
Share-Based Compensation Expense Recognized for Accelerated Vesting of Employee Options | The share-based compensation expense recognized for the accelerated vesting of employee options immediately prior to the acquisition was reported in the Company’s Consolidated Statements of Comprehensive Income for the year ended June 30, 2014 as follows:
(In thousands) |  |  |
Cost of molecular diagnostic testing |  | $ | 185 |
Research and development expense |  |  | 2,075 |
Selling, general, and administrative expense |  |  | 4,669 |
Total share-based compensation |  | $ | 6,929 |
Change of Control Expense Recognized for Bonuses Paid to Crescendo Employees and Directors | The change of control expense recognized for bonuses paid to Crescendo employees and directors for completion of the acquisition with Myriad was reported in the Company’s Consolidated Statements of Comprehensive Income for the year ended June 30, 2014 as follows:
(In thousands) |  |  |
Cost of molecular diagnostic testing |  | $ | 238 |
Research and development expense |  |  | 1,710 |
Selling, general, and administrative expense |  |  | 3,747 |
Total change of control bonuses |  | $ | 5,695 |
Pro-forma Results of Acquisitions | The unaudited pro-forma results presented below include the effects of the Crescendo acquisition as if it had been consummated as of July 1, 2012, with adjustments to give effect to pro forma events that are directly attributable to the acquisition which includes adjustments related to the amortization of acquired intangible assets, interest income and expense, stock-based compensation expense, and depreciation. The unaudited pro forma results do not reflect any operating efficiency or potential cost savings which may result from the consolidation of Crescendo. Accordingly, these unaudited pro forma results are presented for informational purposes only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented nor are they indicative of future results of operations and are not necessarily indicative of either future results of operations or results that might have been achieved had the acquisition been consummated as of July 1, 2012.
(In thousands) |  |  |  |  |  |
|  | June 30, |
|  | 2014 |  |  | 2013 |
Revenue |  | $ | 807,509 |  |  | $ | 619,835 |
Income from operations |  |  | 252,634 |  |  |  | 177,998 |
Net income |  | $ | 155,924 |  |  | $ | 108,024 |
Net income per share, basic |  | $ | 2.06 |  |  | $ | 1.33 |
Net income per share, diluted |  | $ | 1.99 |  |  | $ | 1.30 |

X
- Definition Accrued Compensation And Other Employee Related Benefits Table [Text Block] + References No definition available. + Details
Name: | mygn_AccruedCompensationAndOtherEmployeeRelatedBenefitsTableTextBlock
Namespace Prefix: | mygn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Business Combination Consideration Transferred Table [Text Block] + References No definition available. + Details
Name: | mygn_BusinessCombinationConsiderationTransferredTableTextBlock
Namespace Prefix: | mygn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Schedule Of Share Based Compensation Expense Included In Income Statement [Table Text Block] + References No definition available. + Details
Name: | mygn_ScheduleOfShareBasedCompensationExpenseIncludedInIncomeStatementTableTextBlock
Namespace Prefix: | mygn_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 + Details
Name: | us-gaap_BusinessAcquisitionProFormaInformationTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree. + References Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=39739317&loc=d3e4845-128472 + Details
Name: | us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | nonnum:textBlockItemType
Balance Type: | na
Period Type: | duration